MEI Pharma (MEIP) Stock: Here’s What You Need To Know

MEI Pharma Inc. (NASDAQ:MEIP) On Monday, MEI pharma released results of its phase 2 clinical trial in elderly patients with Acute Myeloid Leukemia – AML. These results were presented at a prestigious medical conference known as the American Society of Hematology or ASH. The results themselves were outstanding, but the stock didn’t budge at all. … Read more

Why The MEI Pharma (MEIP) Stock Decline Isn’t Concerning

MEI Pharma Inc (NASDAQ: MEIP) MEI Pharma stock is taking a crushing blow in the market today. Shortly following the open of the day, the stock started to fall dramatically. Since then, there hasn’t been even the slightest recovery. So, as you can imagine, investors are starting to talk about whether or not MEIP can … Read more

Hot Healthcare Stocks Today | MEIP | GILD | AMRN | MNKD

Gilead Sciences Stocks Are Up (NASDAQ: GILD) I’ve been following Gilead Sciences incredibly close recently. It’s hard not to. After all, the company is the leader in HIV and hepatitis C treatments. Although the stock is down a bit this month, I’m not concerned and don’t think you should be either. As a matter of … Read more

MEI Pharma Stocks Plummet | Poor Trial Results To Blame

MEI Pharma Inc – (NASDAQ: MEIP) MEI Pharma stocks have been plummeting today; falling by nearly 70% so far (12:44). The drop is due to the latest release of clinical testing data of their investigatory cancer drug, Pracinostat. So, today we’ll talk about the trial results and why investors are dumping the stock left and … Read more